JTO Clinical and Research Reports Is Born

por Adjei, Alex A.
Publicado 2020

Our Work Is Done, and You Are in Good Hands

por Adjei, Alex A.
Publicado 2022

A Call for Rapid Submission of Data for Aggregate Review: Can Daily Radiotherapy Imaging Be Used as a Potential Screen for Coronavirus Disease 2019?

por Warren, Graham W., Adjei, Alex A.
Publicado 2020

Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer

por Rivera-Concepcion, Joel, Uprety, Dipesh, Adjei, Alex A.
Publicado 2022

T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions

por Shanshal, Mohamed, Caimi, Paolo F., Adjei, Alex A., Ma, Wen Wee
Publicado 2023

Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center

por Stout, Jeremiah, Smith, Cambray, Buckner, Jan, Adjei, Alex A., Wentworth, Mark, Tilburt, Jon C., Master, Zubin
Publicado 2021

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways

por Zhang, Hao, Shao, Huanjie, Golubovskaya, Vita M, Chen, Hongbin, Cance, William, Adjei, Alex A, Dy, Grace K
Publicado 2016

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

por Parikh, Kaushal, Huether, Robert, White, Kevin, Hoskinson, Derick, Beaubier, Nike, Dong, Haidong, Adjei, Alex A., Mansfield, Aaron S.
Publicado 2020

Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups

por Asmann, Yan W., Parikh, Kaushal, Bergsagel, P. Leif, Dong, Haidong, Adjei, Alex A., Borad, Mitesh J., Mansfield, Aaron S.
Publicado 2021

Trends in Prices of Drugs Used to Treat Metastatic Non–Small Cell Lung Cancer in the US From 2015 to 2020

por Desai, Aakash, Scheckel, Caleb, Jensen, Chelsee J., Orme, Jacob, Williams, Colt, Shah, Nilay, Leventakos, Konstantinos, Adjei, Alex A.
Publicado 2022

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer

por Shi, Huashan, Zhou, Kexun, Cochuyt, Jordan, Hodge, David, Qin, Hong, Manochakian, Rami, Zhao, Yujie, Ailawadhi, Sikander, Adjei, Alex A., Lou, Yanyan
Publicado 2021

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

por Yang, Fang, Wang, Yucai, Tang, Lin, Mansfield, Aaron Scott, Adjei, Alex A., Leventakos, Konstantinos, Duma, Narjust, Wei, Jia, Wang, Lifeng, Liu, Baorui, Molina, Julian R.
Publicado 2022

A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors

por Adjei, Alex A., LoRusso, Patricia, Ribas, Antoni, Sosman, Jeffrey A., Pavlick, Anna, Dy, Grace K., Zhou, Xiaofei, Gangolli, Esha, Kneissl, Michelle, Faucette, Stephanie, Neuwirth, Rachel, Bózon, Viviana
Publicado 2016

Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors

por Katsuta, Eriko, Gil-Moore, Malgorzata, Moore, Justine, Yousif, Mohamed, Adjei, Alex A., Ding, Yi, Caserta, Justin, Baldino, Carmen M., Lee, Kelvin P., Gelman, Irwin H., Takabe, Kazuaki, Opyrchal, Mateusz
Publicado 2022

Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana

por Roberts, Lewis R, Rivers, Brian M, Yates, Clayton C, Newman, Lisa A, Sarkodie, Benjamin D, Davis, Melissa B, Asare-Aboagye, Yaw, Adjei, Alex A, Harris, Adalynn E, Awuah, Baffour
Publicado 2022

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers

por Lou, Yanyan, Dholaria, Bhagirathbhai, Soyano, Aixa, Hodge, David, Cochuyt, Jordan, Manochakian, Rami, Ko, Stephen J., Thomas, Mathew, Johnson, Margaret M., Patel, Neal M., Miller, Robert C., Adjei, Alex A., Ailawadhi, Sikander
Publicado 2018

New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019

por Warren, Graham W., Lim, Vun-Sin, Chowdhary, Mudit, Marwaha, Gaurav, Abd Elbadee, Osama Mostafa, Kirakli, Esra Korkmaz, Billiet, Charlotte, Marin, Alexandra Giraldo, Ramos, Monica, Suppli, Morten Hiul, McGinnis, Gwendolyn J., Adjei, Alex A.
Publicado 2021

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Tre...

por Wang, Xiaofei, Wang, Xiaoyi, Hodgson, Lydia, George, Stephen L., Sargent, Daniel J., Foster, Nate R., Ganti, Apar Kishor, Stinchcombe, Thomas E., Crawford, Jeffrey, Kratzke, Robert, Adjei, Alex A., Kindler, Hedy L., Vokes, Everett E., Pang, Herbert
Publicado 2017

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

por Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M., Ma, Wen Wee, Miller, Austin, Adjei, Alex A., Dy, Grace K.
Publicado 2017

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

por Puzanov, Igor, Sosman, Jeffrey, Santoro, Armando, Saif, Muhammad W., Goff, Laura, Dy, Grace K., Zucali, Paolo, Means-Powell, Julie A., Ma, Wen Wee, Simonelli, Matteo, Martell, Robert, Chai, Feng, Lamar, Maria, Savage, Ronald E., Schwartz, Brian, Adjei, Alex A.
Publicado 2014